Thanks Terry I was about to post this question as I have been trying to understand the vaccines better , cardio cell I am quietly confident on and have my head pretty much around .. The platform potential within the vaccine space is a game changer potentially bigger than any number of vaccines combined ...
The platform / process with protected patents becomes something that many different bios can engage to improve there vaccines with royalties for us on every dose administered
As the Prof mentioned in the video we have to change how we invent vaccines what has worked for 200 years needs updating
HSV-2 Clinical Trial, page-22
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.91 |
Change
-0.090(0.50%) |
Mkt cap ! $344.2M | |||
| Open | High | Low | Value | Volume |
| $18.00 | $18.10 | $17.75 | $74.32K | 4.151K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 681 | $17.90 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.25 | 100 | 1 |
View Market Depth
| Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |